Neurosteroid biosynthetic pathways changes in prefrontal cortex in Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Neurobiology of Aging

• Publication date

  2011-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.neurobiolaging.2009.12.014PMID 20045216
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease.

  2011cited by this paper
• Analysis of Gene Expression in Parkinson's Disease: Possible Involvement of Neurotrophic Support and Axon Guidance in Dopaminergic Cell Death

  2009cited by this paper
• Neurosteroid biosynthesis: enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptides.

  2009cited by this paper
• Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial

  2008cited by this paper
• Hormone replacement therapy for cognitive function in postmenopausal women.

  2008cited by this paper
• Allopregnanolone impairs episodic memory in healthy women

  2008cited by this paper
• Clusters of Hyperactive Neurons Near Amyloid Plaques in a Mouse Model of Alzheimer's Disease

  2008cited by this paper
• Aromatase in the Brain: Not Just for Reproduction Anymore

  2008cited by this paper
• Does progesterone have neuroprotective properties?

  2008cited by this paper
• Estradiol Attenuates Tau Hyperphosphorylation Induced by Upregulation of Protein Kinase-A

  2008cited by this paper
• Neuroactive steroids: State of the art and new perspectives

  2008cited by this paper
• Testosterone supplementation did not prevent cognitive decline or increase bone mineral density in older men

  2008cited by this paper
• Progesterone: therapeutic opportunities for neuroprotection and myelin repair.

  2007cited by this paper
• ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury.

  2007cited by this paper
• Effects of progesterone in the spinal cord of a mouse model of multiple sclerosis.

  2007cited by this paper
• How Progesterone Impairs Memory for Biologically Salient Stimuli in Healthy Young Women

  2007cited by this paper
• Progesterone modulates brain-derived neurotrophic factor and choline acetyltransferase in degenerating Wobbler motoneurons.

  2007cited by this paper
• Regeneration in a Degenerating Brain: Potential of Allopregnanolone as a Neuroregenerative Agent

  2007cited by this paper
• Neurosteroid modulation of synaptic and extrasynaptic GABA(A) receptors.

  2007cited by this paper
• Estrogen, cognition and female ageing.

  2007cited by this paper
• Progesterone inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion

  2007cited by this paper
• Progesterone and Estrogen Regulate Alzheimer-Like Neuropathology in Female 3xTg-AD Mice

  2007cited by this paper
• Androgens Regulate the Development of Neuropathology in a Triple Transgenic Mouse Model of Alzheimer's Disease

  2006cited by this paper
• Plastic neuronal changes in GABA(A) receptor gene expression induced by progesterone metabolites: in vitro molecular and functional studies.

  2006cited by this paper
• Progesterone Increases the Expression of Myelin Basic Protein and the Number of Cells Showing NG2 Immunostaining in the Lesioned Spinal Cord

  2006cited by this paper
• Behavioral correlates of GABAergic disruption in Alzheimer's disease

  2006cited by this paper
• Allopregnanolone, a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion.

  2006cited by this paper
• Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function.

  2006cited by this paper
• Effects of testosterone on cognition and mood in male patients with mild Alzheimer disease and healthy elderly men.

  2006cited by this paper
• Progesterone and progestins: effects on brain, allopregnanolone and beta-endorphin.

  2006cited by this paper
• Testosterone Hormone Replacement Therapy: State-of-the-Art and Emerging Technologies

  2006cited by this paper
• GABAA receptor diversity and pharmacology

  2006cited by this paper
• Androgens, aging, and Alzheimer's disease

  2006cited by this paper
• Neuroactive steroid effects on cognitive functions with a focus on the serotonin and GABA systems.

  2006cited by this paper
• The neurosteroid allopregnanolone is reduced in prefrontal cortex in Alzheimer's disease.

  2006cited by this paper
• Aromatase expression in the human temporal cortex.

  2006cited by this paper
• Steroids, neuroactive steroids and neurosteroids in psychopathology.

  2005cited by this paper
• Type 10 17beta-hydroxysteroid dehydrogenase catalyzing the oxidation of steroid modulators of gamma-aminobutyric acid type A receptors.

  2005cited by this paper
• Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment

  2005cited by this paper
• The Neurosteroids Progesterone and Allopregnanolone Reduce Cell Death, Gliosis, and Functional Deficits after Traumatic Brain Injury in Rats

  2005cited by this paper
• Neurosteroids: endogenous regulators of the GABAA receptor

  2005cited by this paper
• Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors

  2005cited by this paper
• Glia-neuron crosstalk in the neuroprotective mechanisms of sex steroid hormones.

  2005cited by this paper
• Correlations between mental state and quantitative neuropathology in the Vienna Longitudinal Study on Dementia

  2005cited by this paper
• Methodological Issues in Estrogen Treatment Trials for Alzheimer's Disease

  2005cited by this paper
• Distinct patterns of expression and regulation of GABAA receptors containing the δ subunit in cerebellar granule and hippocampal neurons

  2005cited by this paper
• [Diazepam-binding inhibitor].

  2005cited by this paper
• Age-related testosterone depletion and the development of Alzheimer disease.

  2004cited by this paper
• Reduced Progesterone Metabolites Protect Rat Hippocampal Neurones From Kainic Acid Excitotoxicity In Vivo

  2004cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• Characterization of a monoclonal antibody for human aldo-keto reductase AKR1C3 (type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase); immunohistochemical detection in breast and prostate.

  2004cited by this paper
• Allopregnanolone, a progesterone metabolite, enhances behavioral recovery and decreases neuronal loss after traumatic brain injury

  2004cited by this paper
• Neuroprotective role of testosterone in the nervous system.

  2004cited by this paper
• Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

  2003cited by this paper
• Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling

  2003cited by this paper
• Structure–function relationships in 3α-hydroxysteroid dehydrogenases: a comparison of the rat and human isoforms ☆

  2003cited by this paper
• Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by δ subunit-containing GABAA receptors

  2003cited by this paper
• Steroid hormones and neurosteroids in normal and pathological aging of the nervous system.

  2003cited by this paper
• Glutamatergic systems in Alzheimer's disease

  2003cited by this paper
• Estrogen and Alzheimer’s Disease

  2002cited by this paper
• Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

  2002cited by this paper
• Oestrogen as a neuroprotective hormone

  2002cited by this paper
• Neurosteroid quantification in human brain regions: comparison between Alzheimer's and nondemented patients.

  2002cited by this paper
• The influence of subunit composition on the interaction of neurosteroids with GABA(A) receptors.

  2002cited by this paper
• GABAA-receptor plasticity during long-term exposure to and withdrawal from progesterone.

  2001cited by this paper
• Neurosteroid metabolism in the human brain.

  2001cited by this paper
• A new mathematical model for relative quantification in real-time RT-PCR.

  2001cited by this paper
• Biosynthesis of neurosteroids and regulation of their synthesis.

  2001cited by this paper
• Testosterone reduces neuronal secretion of Alzheimer's beta-amyloid peptides.

  2000cited by this paper
• Steroid synthesis and metabolism in the nervous system: Trophic and protective effects

  2000cited by this paper
• Endogenous estrogen levels and Alzheimer’s disease among postmenopausal women

  2000cited by this paper
• Estrogen Enhances Uptake of Amyloid β‐Protein by Microglia Derived from the Human Cortex

  2000cited by this paper
• Progesterone is neuroprotective after acute experimental spinal cord trauma in rats.

  1999cited by this paper
• Progesterone in conjunction with estradiol has neuroprotective effects in an animal model of neurodegeneration.

  1999cited by this paper
• Physiological modulation of GABA(A) receptor plasticity by progesterone metabolites.

  1999cited by this paper
• Neurosteroids: a novel function of the brain.

  1998cited by this paper
• Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis.

  1997cited by this paper
• Pharmacology of Neurosteroid Biosynthesis. Role of the Mitochondrial DBI Receptor (MDR) Complex

  1994cited by this paper
• Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression.

  1993cited by this paper
• Cerebrospinal fluid levels of diazepam‐binding inhibitor in neurodegenerative disorders with dementia

  1990cited by this paper
• Gamma-aminobutyric acid concentration in brain tissue at two stages of Alzheimer's disease.

  1988cited by this paper
• A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer's disease.

  1988cited by this paper
• Diazepam binding inhibitor-like immunoreactivity (DBI-LI) in human CSF. Correlations with neurological disorders.

  1988cited by this paper
• Diazepam-binding inhibitor. A brain neuropeptide present in human spinal fluid: studies in depression, schizophrenia, and Alzheimer's disease.

  1986cited by this paper
• Correlation of cortical cholinergic and GABA deficits with quantitative neuropathological findings in senile dementia.

  1984cited by this paper
• A post-mortem study of the cholinergic and GABA systems in senile dementia.

  1982cited by this paper
• Hormone replacement therapy for cognitive function in postmenopausal women ( Review )

  year unknowncited by this paper

• Default mode network connectivity relates to executive and language performance in patients with mild cognitive impairment.

  2026cites this paper
• Aromatase as a Central Node in Astrocyte Health and Homeostasis

  2025influential citation
• Exploring the mechanism of metabolic cell death-related genes AKR1C2 and MAP1LC3A as biomarkers in Parkinson’s disease

  2025cites this paper
• The role of neuroactive steroids in psychiatric and neurological disorders: Neurobiology and therapeutic perspectives.

  2025cites this paper
• Hypothalamic and hippocampal transcriptome changes in AppNL-G-F mice as a function of metabolic and inflammatory dysfunction.

  2024cites this paper
• Causal influences of testosterone on brain structure change rate: A sex-stratified Mendelian randomization study.

  2024cites this paper
• Sexual and Metabolic Differences in Hippocampal Evolution: Alzheimer’s Disease Implications

  2024cites this paper
• Executive dysfunction is associated with altered hippocampal-prefrontal functional connectivity in 3xTg Alzheimer’s model mice

  2024influential citation
• Neurosteroids and their Therapeutic Potential: Remembering the Contribution of Dr. Sabina Luchetti, Netherlands Institute for Neuroscience, Amsterdam, Netherlands.

  2024cites this paper
• Estrogen and testosterone secretion from the mouse brain.

  2024cites this paper
• Allopregnanolone And Its Antagonist Modulate Neuroinflammation And Neurological Impairment.

  2024cites this paper
• Brain-derived estrogen: a critical player in maintaining cognitive health of aged female rats, possibly involving GPR30.

  2023cites this paper
• Identification of novel genes for age‐at‐onset of Alzheimer's disease by combining quantitative and survival trait analyses

  2023cites this paper
• Identification ferroptosis-related hub genes and diagnostic model in Alzheimer’s disease

  2023cites this paper
• Acyl coenzyme A binding protein (ACBP): An aging‐ and disease‐relevant “autophagy checkpoint”

  2023cites this paper
• Progestogen-Mediated Neuroprotection in Central Nervous System Disorders

  2022cites this paper
• Ovarian steroid hormones: A long overlooked but critical contributor to brain aging and Alzheimer’s disease

  2022cites this paper
• Brain-Derived Estrogen and Neurological Disorders

  2022cites this paper
• Forest Biomass as a Promising Source of Bioactive Essential Oil and Phenolic Compounds for Alzheimer’s Disease Therapy

  2022cites this paper
• An Alzheimer’s Disease Patient-Derived Olfactory Stem Cell Model Identifies Gene Expression Changes Associated with Cognition

  2022cites this paper
• Advances in pharmacotherapy for postpartum depression: a structured review of standard-of-care antidepressants and novel neuroactive steroid antidepressants

  2022cites this paper
• Immunofluorescent Evidence for Nuclear Localization of Aromatase in Astrocytes in the Rat Central Nervous System

  2022cites this paper
• Regulation of Phase I and Phase II Neurosteroid Enzymes in the Hippocampus of an Alzheimer's Disease Rat Model: A Focus on Sulphotransferases and UDP-Glucuronosyltransferases.

  2022cites this paper
• Aromatase in the Human Brain

  2021cites this paper
• Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways

  2021cites this paper
• Brain-derived estrogen and neural function

  2021cites this paper
• Therapeutic potential of pregnenolone and pregnenolone methyl ether on depressive and CDKL5 deficiency disorders: Focus on microtubule targeting

  2021cites this paper
• Progesterone Suppresses Cholesterol Esterification in APP/PS1 mice and a cell model of Alzheimer's Disease.

  2021cites this paper
• Genome-wide DNA methylation analysis of cognitive function in middle and old-aged Chinese monozygotic twins.

  2020cites this paper
• Impaired Expression of GABA Signaling Components in the Alzheimer’s Disease Middle Temporal Gyrus

  2020cites this paper
• A Protective Role of Translocator Protein in Alzheimer's Disease Brain.

  2020cites this paper
• Proteomic investigation of protein adsorption to cerebral microdialysis membranes in surgically treated intracerebral hemorrhage patients - a pilot study

  2020cites this paper
• Steroids and Alzheimer’s Disease: Changes Associated with Pathology and Therapeutic Potential

  2020influential citation
• Expression profiling of precuneus layer III cathepsin D‐immunopositive pyramidal neurons in mild cognitive impairment and Alzheimer's disease: Evidence for neuronal signaling vulnerability

  2020cites this paper
• Sex differences in steroid levels and steroidogenesis in the nervous system: physiopathological role.

  2020cites this paper
• Pregnenolone and pregnenolone-methyl-ether rescue neuronal defects caused by dysfunctional CLIP170 in a neuronal model of CDKL5 Deficiency Disorder.

  2019cites this paper
• Relevance of Steroid Biosynthesis, Metabolism and Transport in Pathophysiology and Drug Discovery

  2019cites this paper
• Neuroactive steroids, neurosteroidogenesis and sex

  2019cites this paper
• Role of hydroxysteroid (17beta) dehydrogenase type 1 in reproductive tissues and hormone-dependent diseases.

  2019cites this paper
• Unsupervised excitation: GABAergic dysfunctions in Alzheimer's disease.

  2019cites this paper
• The impact of sensory and motor enrichment on the epigenetic control of steroidogenic-related genes in rat hippocampus.

  2019cites this paper
• Pharmacotherapy of Postpartum Depression: Current Approaches and Novel Drug Development

  2019cites this paper
• Prelimbic of Medial Prefrontal Cortex GABA Modulation through Testosterone on Spatial Learning and Memory

  2019cites this paper
• Integrating Gene and Protein Expression Reveals Perturbed Functional Networks in Alzheimer’s Disease

  2019cites this paper
• Genome Wide Meta-Analysis identifies common genetic signatures shared by heart function and Alzheimer’s disease

  2019cites this paper
• Involvement of the nitric oxide signaling in modulation of naringin against intranasal manganese and intracerbroventricular β-amyloid induced neurotoxicity in rats.

  2019cites this paper
• GABA-A receptor modulating steroids in acute and chronic stress; relevance for cognition and dementia?

  2019influential citation
• Neurosteroid Metabolites of Gonadal Steroid Hormones in Neuroprotection: Implications for Sex Differences in Neurodegenerative Disease

  2018cites this paper
• Perturbed functional networks in Alzheimer’s Disease reveal opposing roles for TGIF and EGR3

  2018cites this paper
• ONO-8590580, a Novel GABAA α5 Negative Allosteric Modulator Enhances Long-Term Potentiation and Improves Cognitive Deficits in Preclinical Models

  2018cites this paper
• Non-reproductive Functions of Aromatase in the Central Nervous System Under Physiological and Pathological Conditions

  2018cites this paper
• Prefrontal gene expression changes in mood disorders and suicide

  2018cites this paper
• Alterations in the steroid biosynthetic pathways in the human prefrontal cortex in mood disorders: A post‐mortem study

  2018cites this paper
• Intracrine Regulation of Estrogen and Other Sex Steroid Levels in Endometrium and Non-gynecological Tissues; Pathology, Physiology, and Drug Discovery

  2018cites this paper
• Sex steroid hormones as neuroprotective elements in ischemia models.

  2018cites this paper
• Cognitive Effects of Aromatase and Possible Role in Memory Disorders

  2018cites this paper
• Neurosteroids: non‐genomic pathways in neuroplasticity and involvement in neurological diseases

  2018cites this paper
• Sex Impact on Tau-Aggregation and Postsynaptic Protein Levels in the P301L Mouse Model of Tauopathy

  2017cites this paper
• Role of Estrogen and Other Sex Hormones in Brain Aging. Neuroprotection and DNA Repair

  2017cites this paper
• Sex and the development of Alzheimer's disease

  2017cites this paper
• Towards a Better Understanding of GABAergic Remodeling in Alzheimer’s Disease

  2017influential citation
• Progesterone treatment modulates mRNA OF neurosteroidogenic enzymes in a murine model of multiple sclerosis.

  2017cites this paper
• Neuroactive Steroids: Receptor Interactions and Responses

  2017cites this paper
• 1.16 – Ovarian Hormones and Prefrontal Cortex-Related Cognition

  2017cites this paper
• Cortical cells reveal APP as a new player in the regulation of GABAergic neurotransmission

  2017cites this paper
• The neurosteroid pregnenolone reverts microtubule derangement induced by the loss of a functional CDKL5-IQGAP1 complex

  2017cites this paper
• Alzheimer’s disease and cytokine IL-10 gene polymorphisms: is there an association?

  2017cites this paper
• Aromatase Expression in the Hippocampus of AD Patients and 5xFAD Mice

  2016cites this paper
• Pregnancy and lactation differentially modify the transcriptional regulation of steroidogenic enzymes through DNA methylation mechanisms in the hippocampus of aged rats.

  2016cites this paper
• Effect of Estradiol on Neurotrophin Receptors in Basal Forebrain Cholinergic Neurons: Relevance for Alzheimer’s Disease

  2016cites this paper
• Neuroactive Steroids and Neuroinflammation

  2016cites this paper
• Properties of GABAergic inhibition of the medial prefrontal cortex

  2016cites this paper
• Levels and actions of neuroactive steroids in the nervous system under physiological and pathological conditions: Sex-specific features.

  2016cites this paper
• Environmental enrichment attenuates the age-related decline in the mRNA expression of steroidogenic enzymes and reduces the methylation state of the steroid 5α-reductase type 1 gene in the rat hippocampus.

  2015cites this paper
• Investigating the role of filamin C in Belgian patients with frontotemporal dementia linked to GRN deficiency in FTLD-TDP brains

  2015cites this paper
• The impact of luteinizing hormone and testosterone on beta amyloid (Aβ) accumulation: Animal and human clinical studies.

  2015cites this paper
• Analytical challenges for measuring steroid responses to stress, neurodegeneration and injury in the central nervous system.

  2015cites this paper
• Treatment Options in Alzheimer´s Disease: The GABA Story.

  2015cites this paper
• Decreased γ‐aminobutyric acid levels in the parietal region of patients with Alzheimer's disease

  2015cites this paper
• Steroid hormones and homocysteine in the outcome of patients with normal pressure hydrocephalus.

  2015cites this paper
• New steps forward in the neuroactive steroid field.

  2015cites this paper
• Distribution of Estrogen Synthase (Aromatase) in the Human Brain

  2015cites this paper
• Analyse quantitative de l'Estradiol dans les tissus cérébraux et le plasma de souris

  2015cites this paper
• Reduction in Aβ‐induced cell death in the hippocampus of 17β‐estradiol‐treated female rats is associated with an increase in IGF‐I signaling and somatostatinergic tone

  2015cites this paper
• Brain sex matters: estrogen in cognition and Alzheimer's disease.

  2014influential citation
• The neuroprotective actions of oestradiol and oestrogen receptors

  2014cites this paper
• Levels and actions of progesterone and its metabolites in the nervous system during physiological and pathological conditions.

  2014cites this paper
• Not all depression is created equal: sex interacts with disease to precipitate depression

  2013cites this paper
• The sex-specific associations of the aromatase gene with Alzheimer’s disease and its interaction with IL10 in the Epistasis Project

  2013cites this paper
• Comparison of plasma and cerebrospinal fluid levels of neuroactive steroids with their brain, spinal cord and peripheral nerve levels in male and female rats.

  2013cites this paper
• Evidence for Early Cognitive Impairment Related to Frontal Cortex in the 5XFAD Mouse Model of Alzheimer's Disease

  2013cites this paper
• Age-related changes in neuroactive steroid levels in 3xTg-AD mice.

  2013influential citation
• Chapter 102 – Endozepines

  2013cites this paper
• Can noninvasive brain stimulation enhance cognition in neuropsychiatric disorders?

  2013cites this paper
• Metabolic alteration of neuroactive steroids and protective effect of progesterone in Alzheimer's disease-like rats

  2013cites this paper
• LXR and TSPO as new therapeutic targets to increase the levels of neuroactive steroids in the central nervous system of diabetic animals.

  2012cites this paper
• Neuroactive steroids, their metabolites, and neuroinflammation.

  2012cites this paper
• Neurosteroids and the Nervous System

  2012cites this paper
• Expression of aromatase P450(AROM) in the human fetal and early postnatal cerebral cortex.

  2012cites this paper
• Alterations in the histaminergic system in Alzheimer's disease: a postmortem study.

  2012influential citation